Plain-English translation of NCT07215624 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that looks at how surgeons currently prevent blood clots in patients who have had surgery for cancers of the digestive system, reproductive organs, or urinary system. Researchers want to understand what practices surgeons are using, what challenges they face, and whether new decision-support tools could help improve care. The study is asking surgeons and surgical nurse practitioners to share their experiences and practices.
After cancer surgery, patients are at high risk for dangerous blood clots. Research shows that continuing blood clot prevention medicine for a period of time after surgery can help reduce this risk, but doctors don't always prescribe it consistently. This study aims to understand why and how to improve these practices.
You likely qualify if…
You likely don't qualify if…
If you are a surgeon or nurse practitioner, you would complete a survey about your current practices for preventing blood clots after cancer surgery. Some participants may also be asked to participate in an interview to discuss barriers and solutions related to this practice. If you work at a participating site, you may also help extract information from electronic health records to see how often blood clot prevention medicine is being prescribed. The entire process would take place over several months at your workplace.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
United States